Navigation Links
Critically Ill patients ill-equipped to handle end-of life matters

KINGSTON, Ont. –Terminally-ill patients in Canada are not adequately prepared to deal with end-of-life issues- matters concerning resuscitation after a heart attack //or other life-threatening medical complication, says Queen's University professor of Medicine Daren Heyland. A national study has found that only a miniscule number of patients were prepared regarding the different options available to turn the situation around, especially when patients’ condition goes out of hand.

"And if they do have these discussions, elderly patients are ill-equipped to participate in such discussions and to make such decisions," says Dr. Heyland. "The majority of patients do not know much about the process or expected outcomes of resuscitation."

In the study, face-to-face questionnaires were administered at five Canadian hospitals to older patients with end-stage cancer and advanced medical diseases, and where possible to one of their family members. Participants were asked about their information needs regarding the use of CPR as a means of keeping them alive, as well as the decision-making process and the role they wished to play in making this decision.

The Queen's study also underlines the important role of family members, who say they want to be informed and involved in the discussions and decision-making, he adds. Almost 60 per cent of patients and 81 per cent of family members prefer some degree of shared decision-making that includes the family member(s).

"Strategies that improve understanding of resuscitation in the hospital context and that foster discussions between patients, their family members, and physicians may improve the quantity and quality of communication and decision-making at the end of life," Dr. Heyland suggests.

The new findings are published in the September issue of the international journal CHEST, the publication of the American College of Chest Physicians. Also on the research team from Queen'
'"/>




Page: 1 2

Related medicine news :

1. Ultrasound Screening Could Improve The Outcome Of Critically ill Patients
2. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
3. Australia In Search Of A Better Way to Handle Critically Ill Patients and Balance Elective Surgery
4. Drug Trial Goes Foul, Six Volunteers Critically Ill
5. Woman Critically Ill After Getting Wrong Blood
6. Nepals Most Influential Woman Critically Ill
7. Health Care Systems for Critically Ill Patients Need Restructuring
8. HIV infected patients can travel safely abroad
9. New vaccine helps allergy and asthma patients
10. Doctors operate upon patients in candlelight- latest from the quake scene
11. New vaccine helps allergy and asthma patients
Post Your Comments:
(Date:12/2/2008)...ems, part of Life Technologies Corporation (NASDAQ...arch and discovery solutions, today announced that...acturers are implementing its mass spectrometry-ba...rts to identify and contain the spread of melamine...HANGHAI, China & CARLSBAD, Calif. (Business Wire E...
(Date:12/2/2008)... -- Mylan Inc. (NYSE: MYL ) today,announced tha...., have entered,into a settlement agreement with ...d Novartis International AG related to Letrozole T...). , Mylan,s Vice Chairman and CEO Robert J...eached this agreement, which demonstrates our abil...
(Date:12/2/2008)...tCall/ -- Genoptix, Inc. (Nasdaq: GXDX ), a spec...ced the Company,s participation at the RBC Capital...ake place at the Westin New York Hotel at Times Sq...citelli, COO and executive vice president of Genop...onference on Wednesday, December 10, beginning at ...
(Date:12/2/2008)...lif., Dec. 2 ,Attainia and The Nat...they,will deploy Attainia,s suite of web-based bu...sts within the United Kingdom. , "NHSSC has...utions for the,Hospital trusts in the United King..."We recognize that NHSSC is building one of the be...
Breaking Medicine News(10 mins):Health News: Applied Biosystems – Part of Life Technologies – Helps China Respond to Melamine Contamination in Dairy Products : Government and Industry Increase Contaminant Testing to Increase Food Safety 2Health News: Applied Biosystems – Part of Life Technologies – Helps China Respond to Melamine Contamination in Dairy Products : Government and Industry Increase Contaminant Testing to Increase Food Safety 3Health News: Applied Biosystems – Part of Life Technologies – Helps China Respond to Melamine Contamination in Dairy Products : Government and Industry Increase Contaminant Testing to Increase Food Safety 4Health News: Applied Biosystems – Part of Life Technologies – Helps China Respond to Melamine Contamination in Dairy Products : Government and Industry Increase Contaminant Testing to Increase Food Safety 5Health News:Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity 2Health News:Genoptix Announces Participation at the RBC Capital Markets 2008 Healthcare Conference 2Health News:The National Health Service and Attainia Move to Modernize Medical Capital Equipment Budgeting and Planning for the United Kingdom 2
...ven H. Woolf, M.D., professor and director of rese...artment of Family Medicine reported that it will b...stopped spending on improving the medical faciliti...to the public. The congress allocates funds to th...
...s to talk over one’s mobile phone while driving a ...n terms of accuracy and response time, as efficien...ed by structural cognitive limitations, according ...t Professor of Psychology Mei-Ching Lien. This i...
...treatment of breast cancer is the new nine week co...heart problems.// Herceptin is a monoclonal antib...expressed in about 30% of the breast cancers. The...rapy (Herceptin + anthracycline-based chemotherapy...
...he brain spring into action when one if faced with...ng Hsu of the California Institute of Technology i...ity of study participants in two betting games. As... in their brain activity using functional magnetic...
Other Medicine News:Health News:Stop spending on new treatments; allocate funds to improve the existing treatments. 2
(Date:12/2/2008)...irstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a b...tary antibodies for the treatment of cancer, infla...hat it has entered into an agreement expanding its...ingsbridge Capital Limited, a private investment g...ge has committed to provide up to $75 million of c...
(Date:12/1/2008)...ire/ -- New research has found that the availabili...CT) scanner in an emergency room can significantly... a potentially life-saving treatment. Results of t...(NSMC)-Salem Hospital in Salem, Mass., will be pre...ical Society of North America (RSNA). , , "...
(Date:12/1/2008)...PRNewswire-USNewswire/ -- A study has found that p...e for imaging the breast, is not affected by eithe... factors that limit the effectiveness of standard ...ill be presented today at the annual meeting of th..., , "The ability of PEM to detect cancer doe...
(Date:12/1/2008)...FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: ...of the world,s leading medical journals, results o..., experimental compound tasimelteon (VEC-162). Th...Melatonin agonist tasimelteon (VEC-162) for transi...d controlled multicentre trials." Results are repo...
Breaking Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3New Mammography Technology Effective in Detecting Breast Cancer 2New Mammography Technology Effective in Detecting Breast Cancer 3New Mammography Technology Effective in Detecting Breast Cancer 4Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Dynatronics Receives NASDAQ Minimum Bid Price Deficiency Letter 23085 1Dynatronics Receives NASDAQ Minimum Bid Price Deficiency Letter 23085 2Foundation Radiology Group Signs Multi Year Contracts for Diagnostic Services with Pineville Community and Knox County Hospitals 23083 1Foundation Radiology Group Signs Multi Year Contracts for Diagnostic Services with Pineville Community and Knox County Hospitals 23083 2Follow up Phone Surveys 3A Effective Customer Service Assessment Tool for Improving Satisfaction 6344 1Follow up Phone Surveys 3A Effective Customer Service Assessment Tool for Improving Satisfaction 6344 2Newborns in Intensive Care Often Exposed to Pain 23076 1Newborns in Intensive Care Often Exposed to Pain 23076 2Newborns in Intensive Care Often Exposed to Pain 23076 3
...re-FirstCall/ Haemacure,Corporation , a Montreal-b...unced the preliminary findings of the content anal...findings confirm the presence of a number of,prote...orldwide,markets, including albumin, plasminogen, ...a strategic significance for Haemacure as,revenues...
...-FirstCall/ --,Bristol-Myers Squibb Company today ...y of ORENCIA(R) (abatacept) from the open-label,ph...n with juvenile,idiopathic arthritis (JIA) who hav...e-modifying anti- rheumatic drugs (DMARDs), such,a...) antagonists.,The results demonstrated that, afte...
Other Medicine Technology:Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 2Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 3Haemacure Announces Preliminary Findings of its Plasma Discard,Analysis 4Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 2Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 3Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 4Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 5Investigational Study Demonstrated a Re-Establishment of Clinical,Improvement with Orencia (Abatacept) in Children with Juvenile,Idiopathic Arthritis upon Re-Introduction of Therapy 6
...t Lamp is the ideal instrument combination: in nex...to an indirect ophthalmoscope. ,Convenient and ... posterior ocular segments, the HSO 10 Hand Slit L...utstanding benefits for your work include the exce...
The unparalleled Humphrey Lens Analyzers Model 350 and Model 360 with SPEXAN provide the most comprehensive lensometry for your practice. ,Simple to operate, the Humphrey Lens Analyzer (LA) gives f
Lens Loading and Folding for Multipiece & Single-Piece ACRYSOF Lens with Standard Forceps
... is a hospital grade Nd: YAG laser photodisruptor ...se, reliable means for performing posterior capsul... system can be used for the treatment of secondary...ior capsulotomy), and closed-angle glaucoma (irido...
Medicine Products: